ABT - Abbott Laboratories

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5155.37B
Enterprise Value 3171.25B
Trailing P/E 54.16
Forward P/E 124.33
PEG Ratio (5 yr expected) 12.29
Price/Sales (ttm)5.02
Price/Book (mrq)5.02
Enterprise Value/Revenue 35.54
Enterprise Value/EBITDA 623.32

Trading Information

Stock Price History

Beta (3Y Monthly) 0.87
52-Week Change 338.43%
S&P500 52-Week Change 36.04%
52 Week High 388.71
52 Week Low 362.87
50-Day Moving Average 383.38
200-Day Moving Average 377.53

Share Statistics

Avg Vol (3 month) 35.21M
Avg Vol (10 day) 36.37M
Shares Outstanding 51.76B
Float 1.75B
% Held by Insiders 10.72%
% Held by Institutions 176.49%
Shares Short (Jun 28, 2019) 414.15M
Short Ratio (Jun 28, 2019) 42.52
Short % of Float (Jun 28, 2019) 40.83%
Short % of Shares Outstanding (Jun 28, 2019) 40.80%
Shares Short (prior month May 31, 2019) 413.53M

Dividends & Splits

Forward Annual Dividend Rate 41.28
Forward Annual Dividend Yield 41.46%
Trailing Annual Dividend Rate 31.24
Trailing Annual Dividend Yield 31.42%
5 Year Average Dividend Yield 42.02
Payout Ratio 474.07%
Dividend Date 3Aug 15, 2019
Ex-Dividend Date 4Jul 12, 2019
Last Split Factor (new per old) 24798/10000
Last Split Date 3Jan 2, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 9.36%
Operating Margin (ttm)13.77%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)30.93B
Revenue Per Share (ttm)17.54
Quarterly Revenue Growth (yoy)2.70%
Gross Profit (ttm)17.92B
EBITDA 7.34B
Net Income Avi to Common (ttm)2.87B
Diluted EPS (ttm)1.63
Quarterly Earnings Growth (yoy)37.20%

Balance Sheet

Total Cash (mrq)3.26B
Total Cash Per Share (mrq)1.85
Total Debt (mrq)19.96B
Total Debt/Equity (mrq)64.13
Current Ratio (mrq)N/A
Book Value Per Share (mrq)17.53

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A